secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2025-03-05T23:59:59+00:00
Accession:  0001193125-25-046225
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica secures up to $32.5M credit facility; $10M funded at close extends cash runway into mid-2026
--------------------------------------------------------------------------------

- Loan agreement with Avenue Venture Opportunities Fund II provides up to $32.5M; initial tranche $10M funded Feb 28, 2025.
- Additional tranches of $7.5M and $15M available upon achieving clinical milestones and mutual agreement.
- Interest rate: prime + 5% (floor 12.75%); interest-only for 18 months; maturity Sept 1, 2028.
- Warrant issued for 641,163 shares at $2.32 per share; exercisable until Feb 28, 2030.
- No financial covenants; no minimum cash requirement; up to $2M principal convertible at 120% of stock purchase price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312525046225/0001193125-25-046225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312525046225/d940326d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-046225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer